针对不匹配修复缺陷癌症的治疗向
Paul Johannet1, Benoit Rousseau1, Carol Aghajanian1
1Division of Solid Tumour Oncology, Department of Medicine, Memorial Sloan Kettering, New York, NY, USA.
Nature reviews. Clinical oncology
|July 10, 2025
概括
缺少DNA不匹配修复 (MMR) 导致基因组不稳定性和微卫星不稳定性,这是林奇综合征和零星癌症的标志物. MMRd瘤显示出高免疫透率,对免疫检查点抑制剂反应良好,尽管耐药性机制需要进一步研究.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- DNA不匹配修复 (MMR) 通过纠正复制错误来保持基因组完整性.
- 毫米抗缺乏症 (MMRd) 导致微卫星不稳定性 (MSI),这是基因组不稳定的标志.
- MMRd与林奇综合征和零星瘤等遗传性癌症有关.
研究的目的:
- 审查MMR的生物功能和MMRd的基因组后果.
- 检查MMRd的临床影响,包括癌症倾向和诊断.
- 讨论治疗策略,特别是免疫检查点抑制剂 (ICI) 和抵抗机制.
主要方法:
- 关于MMR功能,基因组改变和临床数据的文献综述.
- 分析MSI作为MMRd的生物标志物.
- 检查ICI在MMRd癌症中的疗效和耐药性.
主要成果:
- MMRd导致高突变频率,特别是在微卫星 (MSI-高).
- 高MMRd/MSI的瘤表现出显著的免疫细胞透和免疫检查点上调.
- MMRd癌症对ICI具有显著的敏感性,提供持久的临床益处.
结论:
- MMRd是癌症发展的关键因素,也是ICI反应的预测因素.
- 了解MSI和MMRd对于癌症诊断和治疗选择至关重要.
- 进一步研究MMRd癌症中的ICI耐药机制对于改善患者的治疗结果至关重要.
更多相关视频
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
4.1K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.9K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Nucleotide Excision Repair
3.8K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Base Excision Repair
23.0K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
23.0K
